RecruitingACTRN12609000382279

Regulation of blood fat transport following a fatty test meal in lean men and men with the metabolic syndrome

Novel studies of postparandial lipoprotein metabolism in lean men and men with the metabolic syndrome


Sponsor

Professor Gerald Watts

Enrollment

45 participants

Start Date

Jun 1, 2009

Study Type

Observational

Conditions

Summary

The aim is to carry out a case-control study to demonstrate abnormalities in postprandial lipoprotein metabolism, in men with the metabolic syndrome (MetS) compared with lean men. A further aim is to demonstrate that postprandial lipoprotein metabolism is improved, but not normalized, in men with MetS treated with a statin.


Eligibility

Sex: MalesMin Age: 20 YearssMax Age: 75 Yearss

Plain Language Summary

Simplified for easier understanding

This study is looking at how the body processes fats after eating a high-fat meal in men who have metabolic syndrome (a cluster of health problems including a large waist, high blood fats, and high blood sugar) compared to lean, healthy men. Some of the men with metabolic syndrome will also be taking a cholesterol-lowering drug (Crestor/rosuvastatin). This will help researchers understand how the body handles dietary fat in these different groups. You may be eligible if: - You are a man between 20 and 75 years old - You are a non-smoker - You have metabolic syndrome (with at least 3 of the defining features) OR you are a lean, healthy man with normal blood lipid levels - Your BMI is below 40 (metabolic syndrome group) or below 25 (lean group) You may NOT be eligible if: - You have diabetes mellitus - You have a genetic cholesterol disorder - You drink more than 30 grams of alcohol per day - You have significant liver, kidney, or thyroid problems - You have had a heart attack or cardiovascular event in the past 6 months - You are on a very low-calorie diet or have lactose intolerance Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Observational study. Imediately following a high fat test meal, intravenous D3-leucine stable isotope and two oral vitamin A capsules (50,000U each) will be used as kinetic tracers of lipoprotein meta

Observational study. Imediately following a high fat test meal, intravenous D3-leucine stable isotope and two oral vitamin A capsules (50,000U each) will be used as kinetic tracers of lipoprotein metabolism. This wil be given only once and on one day only.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12609000382279